On the public citation graph

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

0 signed · 966 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1521-4141(200104)31:4<1255::aid-immu1255>3.0.co;2-wopenalex-snapshot

Protection and injury: the differing roles of complement in the development of glomerular injury

inferredcites →https://doi.org/10.1002/art.30141openalex-snapshot

Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice

inferredcites →https://doi.org/10.1002/eji.1830180221openalex-snapshot

The half-lives of serum immunoglobulins in adult mice

inferredcites →https://doi.org/10.1002/eji.1830201011openalex-snapshot

Glycosylation of IgG, immune complexes and IgG subclasses in the MRL‐lpr/lpr mouse model of rheumatoid arthritis

inferredcites →https://doi.org/10.1002/eji.200939884openalex-snapshot

Both FcγRIV and FcγRIII are essential receptors mediating type II and type III autoimmune responses via FcRγ‐LAT‐dependent generation of C5a

inferredcites →https://doi.org/10.1002/eji.201142260openalex-snapshot

IVI g‐mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR 1

inferredcites →https://doi.org/10.1002/eji.201242710openalex-snapshot

B cells and CD 22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo

inferredcites →https://doi.org/10.1002/ibd.21459openalex-snapshot

Functional analysis of agalactosyl IgG in inflammatory bowel disease patients

inferredcites →https://doi.org/10.1002/pbc.20980openalex-snapshot

Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia

inferredcites →https://doi.org/10.1002/pmic.200800931openalex-snapshot

A close look at human IgG sialylation and subclass distribution after lectin fractionation

inferredcites →https://doi.org/10.1006/biol.2001.0279openalex-snapshot

Enhanced Efficacy of Anti-D Immunoglobulin for Treating ITP is not Explained by Higher Immunoglobulin Polymer Content

inferredcites →https://doi.org/10.1007/82_2010_86openalex-snapshot

FcγRs in Health and Disease

inferredcites →https://doi.org/10.1007/s10875-007-9088-9openalex-snapshot

Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action

inferredcites →https://doi.org/10.1007/s10875-010-9398-1openalex-snapshot

Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy

inferredcites →https://doi.org/10.1007/s10875-010-9409-2openalex-snapshot

Analytical and Functional Aspects of Antibody Sialylation

inferredcites →https://doi.org/10.1016/0092-8674(94)90115-5openalex-snapshot

FcR γ chain deletion results in pleiotrophic effector cell defects

inferredcites →https://doi.org/10.1016/0140-6736(93)92000-jopenalex-snapshot

Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura

inferredcites →https://doi.org/10.1016/1074-7613(95)90155-8openalex-snapshot

Cytotoxic antibodies trigger inflammation through Fc receptors

inferredcites →https://doi.org/10.1016/j.autrev.2008.03.015openalex-snapshot

Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: Implications for the clinical use of intravenous immunoglobulins (IVIg)

inferredcites →https://doi.org/10.1016/j.bcp.2011.05.018openalex-snapshot

Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy

inferredcites →https://doi.org/10.1016/j.clim.2009.09.006openalex-snapshot

Exposure of NK cells to intravenous immunoglobulin induces IFNγ release and degranulation but inhibits their cytotoxic activity

inferredcites →https://doi.org/10.1016/j.clindermatol.2011.03.014openalex-snapshot

Current therapy of the pemphigus group

inferredcites →https://doi.org/10.1016/j.immuni.2005.05.010openalex-snapshot

FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity

inferredcites →https://doi.org/10.1016/j.immuni.2005.11.010openalex-snapshot

Fcγ Receptors: Old Friends and New Family Members

inferredcites →https://doi.org/10.1016/j.immuni.2006.11.010openalex-snapshot

FcγRIII-Dependent Inhibition of Interferon-γ Responses Mediates Suppressive Effects of Intravenous Immune Globulin

inferredcites →https://doi.org/10.1016/j.immuni.2011.11.009openalex-snapshot

Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In Vivo

inferredcites →https://doi.org/10.1016/j.intimp.2005.11.003openalex-snapshot

Differences between IGIV products: Impact on clinical outcome

inferredcites →https://doi.org/10.1016/j.jaci.2003.09.045openalex-snapshot

Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations

inferredcites →https://doi.org/10.1016/j.jaci.2007.01.023openalex-snapshot

Intravenous immunoglobulin preparations contain anti–Siglec-8 autoantibodies

inferredcites →https://doi.org/10.1016/j.jaci.2009.03.013openalex-snapshot

Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass

inferredcites →https://doi.org/10.1016/j.jaci.2010.10.030openalex-snapshot

The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

inferredcites →https://doi.org/10.1016/j.molimm.2006.09.005openalex-snapshot

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality

inferredcites →https://doi.org/10.1016/j.tmrv.2007.01.001openalex-snapshot

Guidelines on the Use of Intravenous Immune Globulin for Hematologic Conditions

inferredcites →https://doi.org/10.1016/j.tmrv.2007.12.001openalex-snapshot

The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?

inferredcites →https://doi.org/10.1016/s0065-2776(05)89002-9openalex-snapshot

Negative Signaling in Fc Receptor Complexes

inferredcites →https://doi.org/10.1016/s0065-2776(08)60019-xopenalex-snapshot

Inhibitory Pathways Triggered by ITIM-Containing Receptors

inferredcites →https://doi.org/10.1016/s0140-6736(81)92400-4openalex-snapshot

HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD

inferredcites →https://doi.org/10.1016/s0887-7963(99)80071-6openalex-snapshot

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin

inferredcites →https://doi.org/10.1016/s0952-7915(02)00409-0openalex-snapshot

Fc receptors are major mediators of antibody based inflammation in autoimmunity

inferredcites →https://doi.org/10.1016/s1074-7613(02)00275-3openalex-snapshot

Arthritis Critically Dependent on Innate Immune System Players

inferredcites →https://doi.org/10.1016/s1074-7613(03)00080-3openalex-snapshot

Colony-Stimulating Factor-1-Dependent Macrophages Are Responsible for IVIG Protection in Antibody-Induced Autoimmune Disease

inferredcites →https://doi.org/10.1017/s1462399409001161openalex-snapshot

Low-affinity Fcγ receptors, autoimmunity and infection

inferredcites →https://doi.org/10.1038/316452a0openalex-snapshot

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

inferredcites →https://doi.org/10.1038/379346a0openalex-snapshot

Augmented humoral and anaphylactic responses in FcγRII-deficient mice

inferredcites →https://doi.org/10.1038/icb.2009.36openalex-snapshot

Intravenous immunoglobulin up‐regulates the expression of the inhibitory FcγIIB receptor on B cells

inferredcites →https://doi.org/10.1038/nature10134openalex-snapshot

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

inferredcites →https://doi.org/10.1038/ni.1856openalex-snapshot

Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes

inferredcites →https://doi.org/10.1038/ni1113openalex-snapshot

The complement system in regulation of adaptive immunity

inferredcites →https://doi.org/10.1038/ni1440openalex-snapshot

FcγRIIb controls bone marrow plasma cell persistence and apoptosis

inferredcites →https://doi.org/10.1038/ni833openalex-snapshot

B cells regulate autoimmunity by provision of IL-10

inferredcites →https://doi.org/10.1038/nm1288openalex-snapshot

Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts

inferredcites →https://doi.org/10.1038/nm1416openalex-snapshot

Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

inferredcites →https://doi.org/10.1038/nm836openalex-snapshot

F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

inferredcites →https://doi.org/10.1038/nm921openalex-snapshot

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

inferredcites →https://doi.org/10.1038/nrd2909openalex-snapshot

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

inferredcites →https://doi.org/10.1038/nri2206openalex-snapshot

Fcγ receptors as regulators of immune responses

inferredcites →https://doi.org/10.1038/nri856openalex-snapshot

Roles of Fc receptors in autoimmunity

inferredcites →https://doi.org/10.1038/nrrheum.2011.61openalex-snapshot

Intravenous immunoglobulin therapy in rheumatic diseases

inferredcites →https://doi.org/10.1042/bst0361467openalex-snapshot

Siglecs as positive and negative regulators of the immune system

inferredcites →https://doi.org/10.1046/j.1365-2141.2001.03136.xopenalex-snapshot

IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity

inferredcites →https://doi.org/10.1046/j.1537-2995.1996.36496226146.xopenalex-snapshot

Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti‐D

inferredcites →https://doi.org/10.1046/j.1537-2995.1997.371098016455.xopenalex-snapshot

Monoclonal anti‐D is not effective in the treatment of chronic autoimmune thrombocytopenic purpura

inferredcites →https://doi.org/10.1046/j.1537-2995.1997.37497265347.xopenalex-snapshot

Monoclonal anti‐D is not effective in the treatment of chronic autoimmune thrombocytopenic purpura

inferredcites →https://doi.org/10.1053/bbmt.2002.v8.pm11939601openalex-snapshot

Intravenous immunoglobulin: Appropriate indications and uses in hematopoietic stem cell transplantation

inferredcites →https://doi.org/10.1055/s-0037-1613331openalex-snapshot

Intravenous Immunoglobulin Mediates an Increase in Anti-Platelet Antibody Clearance via the FcRn Receptor

inferredcites →https://doi.org/10.1056/nejm198205273062102openalex-snapshot

Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma Globulin

inferredcites →https://doi.org/10.1056/nejm198605083141907openalex-snapshot

Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody

inferredcites →https://doi.org/10.1067/mai.2002.122466openalex-snapshot

Primary immunodeficiency disorders: Antibody deficiency

inferredcites →https://doi.org/10.1073/pnas.0702936104openalex-snapshot

Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity

inferredcites →https://doi.org/10.1073/pnas.0807319106openalex-snapshot

Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

inferredcites →https://doi.org/10.1073/pnas.0810163105openalex-snapshot

Identification of a receptor required for the anti-inflammatory activity of IVIG

inferredcites →https://doi.org/10.1073/pnas.0915133107openalex-snapshot

A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus

inferredcites →https://doi.org/10.1073/pnas.1009388107openalex-snapshot

Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins

inferredcites →https://doi.org/10.1073/pnas.1014515107openalex-snapshot

FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo

inferredcites →https://doi.org/10.1073/pnas.1108455108openalex-snapshot

Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

inferredcites →https://doi.org/10.1073/pnas.1111810108openalex-snapshot

Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo

inferredcites →https://doi.org/10.1073/pnas.89.8.3325openalex-snapshot

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain.

inferredcites →https://doi.org/10.1073/pnas.93.11.5512openalex-snapshot

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

inferredcites →https://doi.org/10.1074/jbc.m009483200openalex-snapshot

High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR

inferredcites →https://doi.org/10.1074/jbc.m510171200openalex-snapshot

The Carbohydrate at FcγRIIIa Asn-162

inferredcites →https://doi.org/10.1074/jbc.m804617200openalex-snapshot

Phosphoinositide 3-Kinases γ and δ, Linkers of Coordinate C5a Receptor-Fcγ Receptor Activation and Immune Complex-induced Inflammation

inferredcites →https://doi.org/10.1084/jem.164.2.474openalex-snapshot

Blockade of clearance of immune complexes by an anti-F(cγ) receptor monoclonal antibody

inferredcites →https://doi.org/10.1084/jem.184.6.2385openalex-snapshot

Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice

inferredcites →https://doi.org/10.1084/jem.191.8.1293openalex-snapshot

Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III

inferredcites →https://doi.org/10.1084/jem.20011435openalex-snapshot

Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and FcγRII-mediated B Cell Suppression

inferredcites →https://doi.org/10.1084/jem.20012024openalex-snapshot

Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody

inferredcites →https://doi.org/10.1084/jem.20040119openalex-snapshot

The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy

inferredcites →https://doi.org/10.1084/jem.20051503openalex-snapshot

Selective dysregulation of the FcγIIB receptor on memory B cells in SLE

inferredcites →https://doi.org/10.1084/jem.20051900openalex-snapshot

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

inferredcites →https://doi.org/10.1084/jem.20052283openalex-snapshot

Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy

inferredcites →https://doi.org/10.1084/jem.20061788openalex-snapshot

The antiinflammatory activity of IgG: the intravenous IgG paradox

inferredcites →https://doi.org/10.1084/jem.20072565openalex-snapshot

Distinct cell-specific control of autoimmunity and infection by FcγRIIb

inferredcites →https://doi.org/10.1093/hmg/ddi320openalex-snapshot

FcγRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling

inferredcites →https://doi.org/10.1111/j.1365-2249.1993.tb03407.xopenalex-snapshot

Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)

inferredcites →https://doi.org/10.1111/j.1365-2249.2009.04024.xopenalex-snapshot

Clinical applications of intravenous immunoglobulins (IVIg) – beyond immunodeficiencies and neurology

inferredcites →https://doi.org/10.1111/j.1365-2443.2011.01552.xopenalex-snapshot

Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans

inferredcites →https://doi.org/10.1111/j.1398-9995.2011.02579.xopenalex-snapshot

Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes

inferredcites →https://doi.org/10.1111/j.1529-8027.2012.00393.xopenalex-snapshot

Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies

inferredcites →https://doi.org/10.1111/j.1537-2995.2011.03517.xopenalex-snapshot

Sialylation‐independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin

inferredcites →https://doi.org/10.1111/j.1537-2995.2012.03725.xopenalex-snapshot

Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia

inferredcites →https://doi.org/10.1126/science.1105160openalex-snapshot

Restoration of Tolerance in Lupus by Targeted Inhibitory Receptor Expression

inferredcites →https://doi.org/10.1126/science.1118948openalex-snapshot

Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding

inferredcites →https://doi.org/10.1126/science.1129594openalex-snapshot

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

inferredcites →https://doi.org/10.1126/science.1154315openalex-snapshot

Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

inferredcites →https://doi.org/10.1126/science.282.5388.490openalex-snapshot

Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin

inferredcites →https://doi.org/10.1126/science.291.5503.484openalex-snapshot

Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor

inferredcites →https://doi.org/10.1126/science.8066448openalex-snapshot

Fc Receptors Initiate the Arthus Reaction: Redefining the Inflammatory Cascade

inferredcites →https://doi.org/10.1136/gut.31.4.431openalex-snapshot

Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.

inferredcites →https://doi.org/10.1146/annurev-immunol-020711-075018openalex-snapshot

Siglecs and Immune Regulation

inferredcites →https://doi.org/10.1146/annurev.immunol.16.1.421openalex-snapshot

DIVERGENT ROLES FOR F c RECEPTORS AND COMPLEMENT IN VIVO

inferredcites →https://doi.org/10.1146/annurev.immunol.25.022106.141702openalex-snapshot

The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins

inferredcites →https://doi.org/10.1146/annurev.immunol.26.021607.090232openalex-snapshot

Anti-Inflammatory Actions of Intravenous Immunoglobulin

inferredcites →https://doi.org/10.1161/01.cir.0000145143.19711.78openalex-snapshot

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

inferredcites →https://doi.org/10.1172/jci114387openalex-snapshot

Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.

inferredcites →https://doi.org/10.1172/jci16577openalex-snapshot

C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex–induced lung disease

inferredcites →https://doi.org/10.1172/jci200522753openalex-snapshot

Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

inferredcites →https://doi.org/10.1172/jci24394openalex-snapshot

Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases

inferredcites →https://doi.org/10.1172/jci25536openalex-snapshot

Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice

inferredcites →https://doi.org/10.1182/blood-2002-10-3078openalex-snapshot

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG

inferredcites →https://doi.org/10.1182/blood-2003-01-0023openalex-snapshot

IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity

inferredcites →https://doi.org/10.1182/blood-2004-12-4598openalex-snapshot

How I treat idiopathic thrombocytopenic purpura (ITP)

inferredcites →https://doi.org/10.1182/blood-2006-05-021568openalex-snapshot

Immunologic and functional evidence for anti–Siglec-9 autoantibodies in intravenous immunoglobulin preparations

inferredcites →https://doi.org/10.1182/blood-2006-05-023796openalex-snapshot

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

inferredcites →https://doi.org/10.1182/blood-2007-03-079947openalex-snapshot

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

inferredcites →https://doi.org/10.1182/blood-2008-02-138073openalex-snapshot

Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”

inferredcites →https://doi.org/10.1182/blood-2008-07-166439openalex-snapshot

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

inferredcites →https://doi.org/10.1182/blood-2009-10-249466openalex-snapshot

Complement: help or hindrance?

inferredcites →https://doi.org/10.1182/blood-2009-12-261461openalex-snapshot

IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes

inferredcites →https://doi.org/10.1182/blood-2010-01-263533openalex-snapshot

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

inferredcites →https://doi.org/10.1182/blood-2010-03-275123openalex-snapshot

Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice

inferredcites →https://doi.org/10.1182/blood-2010-05-280115openalex-snapshot

Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

inferredcites →https://doi.org/10.1182/blood-2011-08-374223openalex-snapshot

The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody–mediated amelioration of murine immune thrombocytopenia

inferredcites →https://doi.org/10.1182/blood-2012-03-415695openalex-snapshot

Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP

inferredcites →https://doi.org/10.1182/blood.v100.6.2087openalex-snapshot

Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia

inferredcites →https://doi.org/10.1182/blood.v81.1.15.15openalex-snapshot

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient

inferredcites →https://doi.org/10.1182/blood.v88.1.194.194openalex-snapshot

Prospective evaluation of the clinical usefulness of an antigen- specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias

inferredcites →https://doi.org/10.1182/blood.v93.11.3624openalex-snapshot

Inhibition of Cell Adhesion by Antibodies to Arg-Gly-Asp (RGD) in Normal Immunoglobulin for Therapeutic Use (Intravenous Immunoglobulin, IVIg)

inferredcites →https://doi.org/10.1182/blood.v98.4.1095openalex-snapshot

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

inferredcites →https://doi.org/10.1186/ar2892openalex-snapshot

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study

inferredcites →https://doi.org/10.1196/annals.1423.044openalex-snapshot

Intravenous Immunoglobulin and Cytokines

inferredcites →https://doi.org/10.1200/jco.2003.05.013openalex-snapshot

Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma

inferredcites →https://doi.org/10.1200/jco.2007.14.8957openalex-snapshot

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer

inferredcites →https://doi.org/10.1200/jco.2009.25.0274openalex-snapshot

Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma

inferredcites →https://doi.org/10.1201/b10338-4openalex-snapshot

A Historical Review

inferredcites →https://doi.org/10.1371/journal.pone.0021246openalex-snapshot

Enrichment of Sialylated IgG by Lectin Fractionation Does Not Enhance the Efficacy of Immunoglobulin G in a Murine Model of Immune Thrombocytopenia

inferredcites →https://doi.org/10.1371/journal.pone.0031357openalex-snapshot

Intravenous Immunoglobulin Prevents Murine Antibody-Mediated Acute Lung Injury at the Level of Neutrophil Reactive Oxygen Species (ROS) Production

inferredcites →https://doi.org/10.1371/journal.pone.0037243openalex-snapshot

Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation

inferredcites →https://doi.org/10.1586/eci.12.5openalex-snapshot

FcγRIIB: a modulator of cell activation and humoral tolerance

inferredcites →https://doi.org/10.2340/00015555-0249openalex-snapshot

Intravenous Immunoglobulin: Properties, Mode of Action and Practical Use in Dermatology

inferredcites →https://doi.org/10.2340/00015555-1471openalex-snapshot

Analysis of High-dose Intravenous Immunoglobulin Therapy in 16 Patients with Refractory Autoimmune Blistering Skin Disease: High Efficacy and No Serious Adverse Events

inferredcites →https://doi.org/10.3389/fimmu.2011.00096openalex-snapshot

Regulation of B Cell Functions by the Sialic Acid-Binding Receptors Siglec-G and CD22

inferredcites →https://doi.org/10.4049/jimmunol.1102310openalex-snapshot

Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in Mice

inferredcites →https://doi.org/10.4049/jimmunol.143.12.4104openalex-snapshot

Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.

inferredcites →https://doi.org/10.4049/jimmunol.145.6.1794openalex-snapshot

Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp- lpr/lpr mice.

inferredcites →https://doi.org/10.4049/jimmunol.161.7.3781openalex-snapshot

Therapeutic Preparations of Normal Polyspecific IgG (IVIg) Induce Apoptosis in Human Lymphocytes and Monocytes: A Novel Mechanism of Action of IVIg Involving the Fas Apoptotic Pathway

inferredcites →https://doi.org/10.4049/jimmunol.164.2.1065openalex-snapshot

A Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction

inferredcites →https://doi.org/10.4049/jimmunol.174.5.3041openalex-snapshot

Macrophages Induce the Inflammatory Response in the Pulmonary Arthus Reaction through Gαi2 Activation That Controls C5aR and Fc Receptor Cooperation

inferredcites →https://doi.org/10.4049/jimmunol.180.3.1948openalex-snapshot

Differential Contribution of Three Activating IgG Fc Receptors (FcγRI, FcγRIII, and FcγRIV) to IgG2a- and IgG2b-Induced Autoimmune Hemolytic Anemia in Mice

inferredcites →https://doi.org/10.4049/jimmunol.181.10.6829openalex-snapshot

Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between FcγRI and FcγRIV

inferredcites →https://doi.org/10.4414/smw.2012.13593openalex-snapshot

Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4104284openalex-extracted

A Novel Insight Into the Etiology of Haff Disease by Mapping N-Glycome With Orthogonal Mass Spectrometry

inferred← citeshttps://doi.org/10.1002/9781118441213.rtd0019openalex-snapshot

Principles of Systemic Therapy

inferred← citeshttps://doi.org/10.1002/9781119709268.rook019openalex-snapshot

Principles of Systemic Therapy

inferred← citeshttps://doi.org/10.1002/9781683674023.ch95openalex-snapshot

Cardiovascular Diseases

inferred← citeshttps://doi.org/10.1002/acn3.318openalex-snapshot

IVIg attenuates complement and improves spinal cord injury outcomes in mice

inferred← citeshttps://doi.org/10.1002/acn3.326openalex-snapshot

Dose‐dependent inhibition of demyelination and microglia activation by IVIG

inferred← citeshttps://doi.org/10.1002/acn3.687openalex-snapshot

IVI g‐induced plasmablasts in patients with Guillain‐Barré syndrome

inferred← citeshttps://doi.org/10.1002/advs.202100460openalex-snapshot

Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics

inferred← citeshttps://doi.org/10.1002/advs.202104333openalex-snapshot

Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma

inferred← citeshttps://doi.org/10.1002/alz.71865openalex-snapshot

Genetic evidence suggests a protective role of immunoglobulin M in Alzheimer's disease

inferred← citeshttps://doi.org/10.1002/anbr.202200008openalex-snapshot

Engineering Injectable Anti‐Inflammatory Hydrogels to Treat Acute Myocardial Infarction

inferred← citeshttps://doi.org/10.1002/art.38683openalex-snapshot

Interferon‐α Inhibition by Intravenous Immunoglobulin Is Independent of Modulation of the Plasmacytoid Dendritic Cell Population in the Circulation: Comment on the Article by Wiedeman et al

inferred← citeshttps://doi.org/10.1002/art.38910openalex-snapshot

Review: Intravenous Immunoglobulin and B Cells: When the Product Regulates the Producer

inferred← citeshttps://doi.org/10.1002/art.39273openalex-snapshot

Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome

inferred← citeshttps://doi.org/10.1002/art.39611openalex-snapshot

Cγ1 Deficiency Exacerbates Collagen‐Induced Arthritis

inferred← citeshttps://doi.org/10.1002/art.39679openalex-snapshot

IgE Inhibits Toll‐like Receptor 7– and Toll‐like Receptor 9–Mediated Expression of Interferon‐α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus

inferred← citeshttps://doi.org/10.1002/art.70260openalex-snapshot

IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis

inferred← citeshttps://doi.org/10.1002/biot.201700496openalex-snapshot

Alga‐Made Anti‐Hepatitis B Antibody Binds to Human Fcγ Receptors

inferred← citeshttps://doi.org/10.1002/ccr3.1493openalex-snapshot

Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report

inferred← citeshttps://doi.org/10.1002/cyto.b.70041openalex-snapshot

Circulating monocyte partitioning and its alteration in hematological chronic neoplasms

inferred← citeshttps://doi.org/10.1002/eji.201344007openalex-snapshot

B‐cell modulation of dendritic‐cell function: Signals from the far side

inferred← citeshttps://doi.org/10.1002/eji.201344230openalex-snapshot

Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

inferred← citeshttps://doi.org/10.1002/eji.201444700openalex-snapshot

European consensus proposal for immunoglobulin therapies

inferred← citeshttps://doi.org/10.1002/eji.201470045openalex-snapshot

B cells in Multiple Sclerosis: Good or bad guys?

inferred← citeshttps://doi.org/10.1002/eji.201747208openalex-snapshot

IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice

inferred← citeshttps://doi.org/10.1002/eji.202149653openalex-snapshot

Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains

inferred← citeshttps://doi.org/10.1002/hsr2.2239openalex-snapshot

Effect of intravenous immunoglobulin on mortality in hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized controlled trials

inferred← citeshttps://doi.org/10.1002/iid3.167openalex-snapshot

Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?

inferred← citeshttps://doi.org/10.1002/jcb.27821openalex-snapshot

Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function

inferred← citeshttps://doi.org/10.1002/jcp.25091openalex-snapshot

Intravenous Immunoglobulin (IVIG) Attenuates TNF‐Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression

inferred← citeshttps://doi.org/10.1002/jcp.27627openalex-snapshot

NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss

inferred← citeshttps://doi.org/10.1002/jctb.70088openalex-snapshot

Advances in the human immunoglobulin G purification from blood and colostrum via mild chromatographic strategies

inferred← citeshttps://doi.org/10.1002/jmv.26727openalex-snapshot

Administration of intravenous immunoglobulin in the treatment of COVID‐19: A review of available evidence

inferred← citeshttps://doi.org/10.1002/pbc.28075openalex-snapshot

Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia

inferred← citeshttps://doi.org/10.1002/pd.5709openalex-snapshot

A review of fetal and neonatal consequences of maternal systemic lupus erythematosus

inferred← citeshttps://doi.org/10.1002/prca.201500089openalex-snapshot

Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease

inferred← citeshttps://doi.org/10.1002/prca.202000022openalex-snapshot

Revealing the changes of IgG subclass‐specific N‐glycosylation in colorectal cancer progression by high‐throughput assay

inferred← citeshttps://doi.org/10.1002/rmb2.12078openalex-snapshot

Immune modulation of i.v. immunoglobulin in women with reproductive failure

inferred← citeshttps://doi.org/10.1002/rmb2.12561openalex-snapshot

A review of the optimization of thyroid function, thrombophilia, immunity and uterine milieu: OPTIMUM treatment strategy for recurrent implantation failure and recurrent pregnancy loss

inferred← citeshttps://doi.org/10.1007/164_2025_744openalex-snapshot

Role of Antibody Glycosylation in Health, Disease, and Therapy

inferred← citeshttps://doi.org/10.1007/7355_2015_5005openalex-snapshot

Characterization of Therapeutic Proteins

inferred← citeshttps://doi.org/10.1007/82_2017_23openalex-snapshot

Authentic IgM Fc Receptor (FcμR)

inferred← citeshttps://doi.org/10.1007/82_2019_148openalex-snapshot

Anti-inflammatory Activity of IgG-Fc

inferred← citeshttps://doi.org/10.1007/978-1-0716-5376-0_12openalex-snapshot

A Detailed Protocol to Induce and Treat Passive Immune Thrombocytopenia in Mice

inferred← citeshttps://doi.org/10.1007/978-1-4939-6493-2_1openalex-snapshot

Ubiquitous Importance of Protein Glycosylation

inferred← citeshttps://doi.org/10.1007/978-1-4939-8958-4_20openalex-snapshot

A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors

inferred← citeshttps://doi.org/10.1007/978-3-030-10811-3_20openalex-snapshot

Plasma-Derived Immunoglobulins

inferred← citeshttps://doi.org/10.1007/978-3-030-24970-0_7openalex-snapshot

IgG Glycans as a Biomarker of Biological Age

inferred← citeshttps://doi.org/10.1007/978-3-030-57616-5_8openalex-snapshot

Treatment of Necrotizing Soft Tissue Infections: IVIG

inferred← citeshttps://doi.org/10.1007/978-3-030-76912-3_12openalex-snapshot

Sweet Rules: Linking Glycosylation to Antibody Function

inferred← citeshttps://doi.org/10.1007/978-3-030-76912-3_13openalex-snapshot

Immunoglobulin G Glycosylation in Diseases

inferred← citeshttps://doi.org/10.1007/978-3-030-76912-3_17openalex-snapshot

The Rapidly Expanding Nexus of Immunoglobulin G N-Glycomics, Suboptimal Health Status, and Precision Medicine

inferred← citeshttps://doi.org/10.1007/978-3-030-76912-3_18openalex-snapshot

Glycosylation of Antigen-Specific Antibodies: Perspectives on Immunoglobulin G Glycosylation in Vaccination and Immunotherapy

inferred← citeshttps://doi.org/10.1007/978-3-030-76912-3_9openalex-snapshot

Epigenetics of Immunoglobulin G Glycosylation

inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_232-1openalex-snapshot

The Role of Immunotherapy in Renal Cell Carcinoma

inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_232-2openalex-snapshot

Immunotherapy for Renal Cell Carcinoma

inferred← citeshttps://doi.org/10.1007/978-3-030-90225-4_28openalex-snapshot

Intravenous Immunoglobulin

inferred← citeshttps://doi.org/10.1007/978-3-031-18591-5_13openalex-snapshot

Strategies to Reduce Endotoxin Activity

inferred← citeshttps://doi.org/10.1007/978-3-031-40658-4_44openalex-snapshot

Immune-Targeted Therapies in SSc

inferred← citeshttps://doi.org/10.1007/978-3-031-85870-3_10openalex-snapshot

A New Metric to Classify B Cell Lineage Tree

inferred← citeshttps://doi.org/10.1007/978-3-031-88290-6_7openalex-snapshot

The Sensitized Patient Awaiting Heart Transplantation

inferred← citeshttps://doi.org/10.1007/978-3-032-00769-8_232openalex-snapshot

Immunotherapy for Renal Cell Carcinoma

inferred← citeshttps://doi.org/10.1007/978-3-319-07911-0_18openalex-snapshot

Sweet and Sour: The Role of Glycosylation for the Anti-inflammatory Activity of Immunoglobulin G

inferred← citeshttps://doi.org/10.1007/978-3-319-08046-8_3openalex-snapshot

Role of the Innate and Adaptive Immune System in the Pathogenesis of PD

inferred← citeshttps://doi.org/10.1007/978-3-319-33429-5_18openalex-snapshot

Can Intravenous Human Immunoglobulins Reduce Mortality in Patients with (Septic) Acute Kidney Injury?

inferred← citeshttps://doi.org/10.1007/978-3-319-43359-2_5openalex-snapshot

Immune-Mediated Mechanisms of Proteinuria

inferred← citeshttps://doi.org/10.1007/978-3-319-43773-6_6openalex-snapshot

The Sensitized Patient Awaiting Heart Transplantation

inferred← citeshttps://doi.org/10.1007/978-3-319-68038-5_11openalex-snapshot

Basics of Immunoglobulins as Effector Molecules and Drugs

inferred← citeshttps://doi.org/10.1007/978-3-319-68038-5_13openalex-snapshot

Current IgG Products and Future Perspectives

inferred← citeshttps://doi.org/10.1007/978-3-319-68038-5_6openalex-snapshot

Mechanisms of Action and Immunomodulation by IVIg

inferred← citeshttps://doi.org/10.1007/978-3-319-77674-3_17openalex-snapshot

Role of Immunoglobulin Therapy to Prevent and Treat Infections

inferred← citeshttps://doi.org/10.1007/978-3-319-90933-2_7openalex-snapshot

Antibody Mediated Rejection: Are We There Yet?

inferred← citeshttps://doi.org/10.1007/978-4-431-55855-2_17openalex-snapshot

C-Type Lectin Receptors

inferred← citeshttps://doi.org/10.1007/978-981-10-3886-0_9openalex-snapshot

Pathogenesis and Treatment of Hemophilia

inferred← citeshttps://doi.org/10.1007/978-981-10-4142-6_14openalex-snapshot

High-Dose Immunoglobulin

inferred← citeshttps://doi.org/10.1007/978-981-10-7046-4_7openalex-snapshot

Treatment of Rejection in Desensitized KT Patients

inferred← citeshttps://doi.org/10.1007/978-981-10-7338-0_26openalex-snapshot

Immunotherapy for Recurrent Miscarriages

inferred← citeshttps://doi.org/10.1007/978-981-10-8690-8_8openalex-snapshot

Previous Trial Studies of Unexplained Recurrent Miscarriage

inferred← citeshttps://doi.org/10.1007/978-981-16-7200-2_8openalex-snapshot

Biologics in Systemic Sclerosis

inferred← citeshttps://doi.org/10.1007/978-981-19-5759-8_14openalex-snapshot

Novel Conceptions in Treatments of Fulminant Myocarditis

inferred← citeshttps://doi.org/10.1007/978-981-97-0511-5_11openalex-snapshot

Non B Cell-Derived Immunoglobulins in Intestinal Tract

inferred← citeshttps://doi.org/10.1007/s00005-016-0422-xopenalex-snapshot

Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations

inferred← citeshttps://doi.org/10.1007/s00105-020-04610-6openalex-snapshot

Europäische Leitlinien (S1) für die Verwendung von hoch dosierten intravenösen Immunglobulinen in der Dermatologie

inferred← citeshttps://doi.org/10.1007/s00125-017-4403-3openalex-snapshot

Relapsing/remitting type 1 diabetes

inferred← citeshttps://doi.org/10.1007/s00134-014-3506-2openalex-snapshot

A revival for immunoglobulin therapy in septic shock?

inferred← citeshttps://doi.org/10.1007/s00281-014-0424-xopenalex-snapshot

B cells in MS and NMO: pathogenesis and therapy

inferred← citeshttps://doi.org/10.1007/s00281-014-0427-7openalex-snapshot

Targeting B cells and autoantibodies in the therapy of autoimmune diseases

inferred← citeshttps://doi.org/10.1007/s00281-014-0466-0openalex-snapshot

The protective role of immunoglobulins in fungal infections and inflammation

inferred← citeshttps://doi.org/10.1007/s00296-024-05613-5openalex-snapshot

Efficacy and safety of intravenous immunoglobulin therapy in systemic sclerosis: a systematic review

inferred← citeshttps://doi.org/10.1007/s00347-016-0263-3openalex-snapshot

Immunmodulatorische Therapie bei Autoimmunerkrankungen

inferred← citeshttps://doi.org/10.1007/s00438-017-1297-1openalex-snapshot

Semax, an analog of ACTH(4−7), regulates expression of immune response genes during ischemic brain injury in rats

inferred← citeshttps://doi.org/10.1007/s10156-013-0629-2openalex-snapshot

Neonatal hemophagocytic lymphohistiocytosis associated with a vertical transmission of coxsackievirus B1

inferred← citeshttps://doi.org/10.1007/s10719-018-9820-0openalex-snapshot

Serum sialylation changes in cancer

inferred← citeshttps://doi.org/10.1007/s10792-015-0051-0openalex-snapshot

Clinical outcomes of intravenous immunoglobulin therapy in refractory uveitis

inferred← citeshttps://doi.org/10.1007/s10875-014-0031-6openalex-snapshot

Role of FcγRIIIA (CD16) in IVIg-Mediated Anti-Inflammatory Function

inferred← citeshttps://doi.org/10.1007/s10875-014-0120-6openalex-snapshot

Modulatory Role of Intravenous Gammaglobulin (IgIV) on the in vitro Antibody Response to a Pneumococcal Polysaccharide Antigen

inferred← citeshttps://doi.org/10.1007/s10875-016-0249-6openalex-snapshot

Translating Inhibitory Fc Receptor Biology into Novel Therapeutic Approaches

inferred← citeshttps://doi.org/10.1007/s10875-016-0253-xopenalex-snapshot

The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases

inferred← citeshttps://doi.org/10.1007/s10875-022-01277-7openalex-snapshot

Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients

inferred← citeshttps://doi.org/10.1007/s10875-024-01742-5openalex-snapshot

Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or without Dose Ramp-Up: A Phase 1 Study in Healthy Participants

inferred← citeshttps://doi.org/10.1007/s11033-026-12514-2openalex-snapshot

Immunoglobulins in recurrent pregnancy loss: Emerging biomarkers and therapeutic targets

inferred← citeshttps://doi.org/10.1007/s11046-022-00685-yopenalex-snapshot

Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review

inferred← citeshttps://doi.org/10.1007/s11882-016-0632-7openalex-snapshot

Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity

inferred← citeshttps://doi.org/10.1007/s12016-021-08891-0openalex-snapshot

Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies

inferred← citeshttps://doi.org/10.1007/s12016-025-09110-wopenalex-snapshot

COVID-19-associated Autoimmune and Inflammatory Diseases: Molecular Mechanisms and the Role of IVIG Therapy

inferred← citeshttps://doi.org/10.1007/s12017-019-08571-5openalex-snapshot

Intravenous Immunoglobulin (IVIg) Induce a Protective Phenotype in Microglia Preventing Neuronal Cell Death in Ischaemic Stroke

inferred← citeshttps://doi.org/10.1007/s12026-014-8580-6openalex-snapshot

Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients

inferred← citeshttps://doi.org/10.1007/s12026-014-8599-8openalex-snapshot

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21low B cells

inferred← citeshttps://doi.org/10.1007/s12026-014-8615-zopenalex-snapshot

Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future

inferred← citeshttps://doi.org/10.1007/s12026-024-09565-7openalex-snapshot

Targeting the neonatal Fc receptor (FcRn) is not beneficial in an animal model of chronic neuritis

inferred← citeshttps://doi.org/10.1007/s12035-017-0394-9openalex-snapshot

Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke

inferred← citeshttps://doi.org/10.1007/s12185-025-04020-1openalex-snapshot

Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipient

inferred← citeshttps://doi.org/10.1007/s13167-025-00416-5openalex-snapshot

Establishment of reference intervals for serum immunoglobulin G N-glycosylation features in healthy Chinese adults: a nationwide survey in the framework of predictive, preventive, and personalized medicine

inferred← citeshttps://doi.org/10.1007/s13311-015-0391-5openalex-snapshot

Efficacy of Intravenous Immunoglobulin in Neurological Diseases

inferred← citeshttps://doi.org/10.1007/s13311-020-00921-7openalex-snapshot

Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis

inferred← citeshttps://doi.org/10.1007/s40120-026-00923-1openalex-snapshot

Efgartigimod in Patients with Generalized Myasthenia Gravis Refractory or Intolerant to IVIg

inferred← citeshttps://doi.org/10.1007/s40136-014-0057-6openalex-snapshot

Immunology of Transplant Protocols

inferred← citeshttps://doi.org/10.1007/s40257-022-00699-8openalex-snapshot

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments

inferred← citeshttps://doi.org/10.1007/s40259-025-00708-2openalex-snapshot

Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress

inferred← citeshttps://doi.org/10.1007/s40262-026-01641-5openalex-snapshot

Population Pharmacokinetics and Pharmacodynamics of Immunoglobulins: A Systematic Review

inferred← citeshttps://doi.org/10.1007/s40263-015-0279-2openalex-snapshot

Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics

inferred← citeshttps://doi.org/10.1007/s40272-024-00627-9openalex-snapshot

Advances in Immune Tolerance Induction in Enzyme Replacement Therapy

inferred← citeshttps://doi.org/10.1007/s40291-024-00733-xopenalex-snapshot

Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy

inferred← citeshttps://doi.org/10.1016/b978-0-08-100623-8.00043-8openalex-snapshot

Current Manufacturing of Human Plasma Immunoglobulin G

inferred← citeshttps://doi.org/10.1016/b978-0-12-374279-7.15015-5openalex-snapshot

Transplantation Immunology: Kidney and Liver

inferred← citeshttps://doi.org/10.1016/b978-0-12-394802-1.00011-xopenalex-snapshot

Activating and Inhibitory FcγRs in Autoimmune Disorders

inferred← citeshttps://doi.org/10.1016/b978-0-12-405546-9.00056-xopenalex-snapshot

Immunoglobulin Replacement

inferred← citeshttps://doi.org/10.1016/b978-0-12-816126-5.00006-8openalex-snapshot

Sialic acids in autoimmune disorders

inferred← citeshttps://doi.org/10.1016/b978-0-12-819475-1.00076-6openalex-snapshot

Common Cellular Glycans: Biosynthesis, Modifications and Functions in Cancer and Inflammation

inferred← citeshttps://doi.org/10.1016/b978-0-12-819475-1.00086-9openalex-snapshot

Systems Glycobiology: Immunoglobulin G Glycans as Biomarkers and Functional Effectors in Aging and Diseases

inferred← citeshttps://doi.org/10.1016/b978-0-12-820583-9.00003-8openalex-snapshot

Passively acquired lupus in the fetus and neonate

inferred← citeshttps://doi.org/10.1016/b978-0-12-824465-4.00154-xopenalex-snapshot

Transplantation Immunology: Kidney and liver

inferred← citeshttps://doi.org/10.1016/b978-0-323-90805-4.00019-5openalex-snapshot

T helper cell pathology and recurrent pregnancy losses; Th1/Th2, Treg/Th17, and other T cell responses

inferred← citeshttps://doi.org/10.1016/b978-0-323-95702-1.00230-xopenalex-snapshot

Complement Pathways

inferred← citeshttps://doi.org/10.1016/b978-0-443-11611-7.00110-9openalex-snapshot

Therapeutic plasma exchange and intravenous immunoglobulin therapy

inferred← citeshttps://doi.org/10.1016/b978-0-443-11980-4.00013-1openalex-snapshot

Therapeutics: Biologics and Targeted Small Molecules

inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00005-9openalex-snapshot

Adaptive Immunity

inferred← citeshttps://doi.org/10.1016/b978-84-9022-857-9.50056-7openalex-snapshot

10.1016/b978-84-9022-857-9.50056-7

inferred← citeshttps://doi.org/10.1016/bs.acc.2021.02.001openalex-snapshot

IgG N-glycans

inferred← citeshttps://doi.org/10.1016/bs.irn.2025.04.018openalex-snapshot

Rescue therapy in myasthenia gravis

inferred← citeshttps://doi.org/10.1016/j.aca.2016.08.014openalex-snapshot

Determination of the composition, encapsulation efficiency and loading capacity in protein drug delivery systems using circular dichroism spectroscopy

inferred← citeshttps://doi.org/10.1016/j.actpha.2013.07.007openalex-snapshot

Immunoglobulines : des cibles multiples

inferred← citeshttps://doi.org/10.1016/j.addr.2019.03.004openalex-snapshot

Scaffold-mediated sequential drug/gene delivery to promote nerve regeneration and remyelination following traumatic nerve injuries

inferred← citeshttps://doi.org/10.1016/j.amjoto.2021.102963openalex-snapshot

Role of tonsillectomy and adenoidectomy in parental satisfaction of treatments for PANDAS

inferred← citeshttps://doi.org/10.1016/j.anai.2024.08.021openalex-snapshot

Inflammatory pathways in patients with post-acute sequelae of COVID-19

inferred← citeshttps://doi.org/10.1016/j.aninu.2021.09.002openalex-snapshot

Supplementing daidzein in diets improves the reproductive performance, endocrine hormones and antioxidant capacity of multiparous sows

inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.01.002openalex-snapshot

The role of adjuvant immunomodulatory agents for treatment of severe influenza

inferred← citeshttps://doi.org/10.1016/j.ard.2025.09.011openalex-snapshot

Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study

inferred← citeshttps://doi.org/10.1016/j.autrev.2014.02.005openalex-snapshot

Impact of autoantibody glycosylation in autoimmune diseases

inferred← citeshttps://doi.org/10.1016/j.autrev.2014.08.018openalex-snapshot

Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review

inferred← citeshttps://doi.org/10.1016/j.autrev.2016.02.006openalex-snapshot

Targeting FcγRs to treat antibody-dependent autoimmunity

inferred← citeshttps://doi.org/10.1016/j.autrev.2016.03.018openalex-snapshot

IVIG in autoimmune disease — Potential next generation biologics

inferred← citeshttps://doi.org/10.1016/j.autrev.2016.07.035openalex-snapshot

Fc-gamma receptors: Attractive targets for autoimmune drug discovery searching for intelligent therapeutic designs

inferred← citeshttps://doi.org/10.1016/j.autrev.2017.02.008openalex-snapshot

Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature

inferred← citeshttps://doi.org/10.1016/j.autrev.2017.11.027openalex-snapshot

IgE in lupus pathogenesis: Friends or foes?

inferred← citeshttps://doi.org/10.1016/j.autrev.2021.102804openalex-snapshot

Antibody glycosylation in autoimmune diseases

inferred← citeshttps://doi.org/10.1016/j.autrev.2023.103441openalex-snapshot

Immunoglobulins in systemic sclerosis management. A large multicenter experience

inferred← citeshttps://doi.org/10.1016/j.bbagen.2015.10.016openalex-snapshot

Mechanisms of disease: The human N-glycome

inferred← citeshttps://doi.org/10.1016/j.bbagen.2016.04.016openalex-snapshot

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies

inferred← citeshttps://doi.org/10.1016/j.bbagen.2019.07.001openalex-snapshot

Inflammatory bowel disease - glycomics perspective

inferred← citeshttps://doi.org/10.1016/j.bbagen.2019.129510openalex-snapshot

Profiling of isomer-specific IgG N-glycosylation in cohort of Chinese colorectal cancer patients

inferred← citeshttps://doi.org/10.1016/j.bbmt.2015.01.006openalex-snapshot

Role of Natural Killer Cells in Intravenous Immunoglobulin–Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg−/− (NSG) Mice

inferred← citeshttps://doi.org/10.1016/j.bej.2024.109501openalex-snapshot

Application of flowsheet modeling for scheduling and debottlenecking analysis to support the development and scale-up of a plasma-derived therapeutic protein purification process

inferred← citeshttps://doi.org/10.1016/j.biologicals.2017.11.001openalex-snapshot

Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential

inferred← citeshttps://doi.org/10.1016/j.biopha.2017.06.001openalex-snapshot

Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)

inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114851openalex-snapshot

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients

inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119762openalex-snapshot

Intravenous immunoglobulin therapy in viral infections: Lessons learned from COVID-19

inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119831openalex-snapshot

Intravenous immunoglobulin recalibrates monocyte responses to abortive SARS-CoV-2 infection across viral variants

inferred← citeshttps://doi.org/10.1016/j.biopsych.2013.07.041openalex-snapshot

Brain Biopsy Findings Link Major Depressive Disorder to Neuroinflammation, Oxidative Stress, and Neurovascular Dysfunction: A Case Report

inferred← citeshttps://doi.org/10.1016/j.biotechadv.2023.108201openalex-snapshot

Modulating antibody effector functions by Fc glycoengineering

inferred← citeshttps://doi.org/10.1016/j.biotechadv.2023.108206openalex-snapshot

Glycosylation Shapes the Efficacy and Safety of Diverse Protein, Gene and Cell Therapies

inferred← citeshttps://doi.org/10.1016/j.canlet.2022.215902openalex-snapshot

Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications

inferred← citeshttps://doi.org/10.1016/j.ccc.2017.08.007openalex-snapshot

Management of Sepsis-Induced Immunosuppression

inferred← citeshttps://doi.org/10.1016/j.cell.2017.11.041openalex-snapshot

Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease

inferred← citeshttps://doi.org/10.1016/j.cellimm.2018.03.014openalex-snapshot

IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids

inferred← citeshttps://doi.org/10.1016/j.cellimm.2018.07.007openalex-snapshot

Glycans as critical regulators of gut immunity in homeostasis and disease

inferred← citeshttps://doi.org/10.1016/j.cellimm.2018.07.009openalex-snapshot

Immunoglobulin G glycosylation in aging and diseases

inferred← citeshttps://doi.org/10.1016/j.celrep.2015.09.013openalex-snapshot

Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized Mice

inferred← citeshttps://doi.org/10.1016/j.celrep.2015.11.027openalex-snapshot

A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors

inferred← citeshttps://doi.org/10.1016/j.chom.2018.06.012openalex-snapshot

Immune Correlate-Guided HIV Vaccine Design

inferred← citeshttps://doi.org/10.1016/j.cjche.2015.06.019openalex-snapshot

Experimental and in silico studies on three hydrophobic charge-induction adsorbents for porcine immunoglobulin purification

inferred← citeshttps://doi.org/10.1016/j.cld.2022.03.001openalex-snapshot

Biliary Atresia in Children

inferred← citeshttps://doi.org/10.1016/j.clim.2015.05.003openalex-snapshot

Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells

inferred← citeshttps://doi.org/10.1016/j.clim.2018.10.018openalex-snapshot

IVIG induces apoptotic cell death in CD56dim NK cells resulting in inhibition of ADCC effector activity of human PBMC

inferred← citeshttps://doi.org/10.1016/j.clim.2020.108459openalex-snapshot

Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!

inferred← citeshttps://doi.org/10.1016/j.clim.2020.108541openalex-snapshot

The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease

inferred← citeshttps://doi.org/10.1016/j.clim.2022.108955openalex-snapshot

Time course of peripheral immunophenotypes of multisystem inflammatory syndrome in children

inferred← citeshttps://doi.org/10.1016/j.clim.2025.110457openalex-snapshot

The efficacy and safety between efgartigimod and intravenous immunoglobulin in elderly generalized myasthenia gravis patients

inferred← citeshttps://doi.org/10.1016/j.clinthera.2019.07.009openalex-snapshot

Efficacy and Tolerability of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Neurologic Diseases

inferred← citeshttps://doi.org/10.1016/j.cmi.2020.10.010openalex-snapshot

Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series

inferred← citeshttps://doi.org/10.1016/j.cmi.2021.05.012openalex-snapshot

Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study

inferred← citeshttps://doi.org/10.1016/j.coco.2024.102112openalex-snapshot

A readily accessible quaternized cellulose filter paper with high permeability for IgG separation

inferred← citeshttps://doi.org/10.1016/j.copbio.2014.06.014openalex-snapshot

Diversity in structure and functions of antibody sialylation in the Fc

inferred← citeshttps://doi.org/10.1016/j.coph.2014.05.002openalex-snapshot

Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases

inferred← citeshttps://doi.org/10.1016/j.crbiot.2025.100333openalex-snapshot

Validation of adventitious agent safety in Yimmugo®, a novel IVIG preparation for human use

inferred← citeshttps://doi.org/10.1016/j.ctrv.2020.102041openalex-snapshot

Cancer and COVID-19: Unmasking their ties

inferred← citeshttps://doi.org/10.1016/j.cveq.2014.04.005openalex-snapshot

Update on the Management of Neonatal Sepsis in Horses

inferred← citeshttps://doi.org/10.1016/j.cyto.2014.10.016openalex-snapshot

Involvement of the TNF-α/TGF-β/IDO axis in IVIg-induced immune tolerance

inferred← citeshttps://doi.org/10.1016/j.drudis.2016.08.004openalex-snapshot

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease

inferred← citeshttps://doi.org/10.1016/j.ebiom.2017.04.021openalex-snapshot

Immunoglobulin Infusion as Therapy Against Influenza?

showing the first 200 of 806

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.